Clinical Trial Sheds Light on Daily CBD Use and Liver Enzymes
UNITED STATES, JUL 7 – A four-week trial found 5% of participants had elevated liver enzymes after low-dose CBD use, raising concerns about liver safety in widespread over-the-counter products.
3 Articles
3 Articles
Everyday CBD Use Brings Risk to Liver
As cannabidiol (CBD) products become a fixture in American homes, a new FDA study has found that even low doses may quietly harm the liver in some users. Researchers conducted a placebo-controlled study with 201 healthy adults, giving some participants a common consumer dose of CBD for four weeks. While...
Clinical Trial Sheds Light on Daily CBD Use and Liver Enzymes
(MedPage Today) -- Daily use of cannabidiol (CBD) at doses commonly reported by consumers was associated with potentially dangerous increases in liver enzymes, a randomized clinical trial found. Among 201 healthy adult participants followed for...
Coverage Details
Bias Distribution
- 67% of the sources lean Left
To view factuality data please Upgrade to Premium